Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
High MAC-The First Affiliated Hospital of Anhui Medical University refers to a specific high-concentration dosing regimen of the volatile anesthetic sevoflurane used in clinical research. Specifically, it is a treatment arm in a randomized clinical trial (NCT04292561) conducted by The First Affiliated Hospital of Anhui Medical University to investigate the effects of deep versus light anesthesia on postoperative delirium (POD) and intraoperative electroencephalogram (EEG) patterns in elderly patients undergoing abdominal surgery. Sevoflurane, the active agent, is a small molecule inhalational anesthetic that functions primarily as a positive allosteric modulator of GABA-A receptors and an antagonist of NMDA receptors, leading to central nervous system depression and general anesthesia. The High MAC designation indicates a target minimum alveolar concentration (MAC) typically ranging from 1.0 to 2.0, intended to maintain a deeper state of anesthesia compared to Low MAC protocols.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on High MAC-The First Affiliated Hospital of Anhui Medical University.